Previous Close | 4.95 |
1-Year Change | 12.76% |
6-Months Change | 30.26% |
3-Months Change | -17.22% |
Moving Avg (50d) | 5.4628 |
Moving Avg (200d) | 4.7686 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 284.8M |
Beta (3-Years) | 0.71 |
Revenue Growth (ttm) | -17.86% |
Net Profit Margin (ttm) | 5.56% |
Return On Assets (ttm) | 1.83% |
EPS (ttm) | 0.21 |
PE Ratio (ttm) | 23.57 |
Dividend Yield | % |
Asset Description: | Vanda Pharmaceuticals Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-08-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
5.049 | 5.197 | 5.296 | 5.445 | 5.692 | 5.94 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |